Qualigen Therapeutics, Inc. Common Stock (QLGN) Free Cash Flow (2020 - 2025)
Qualigen Therapeutics, Inc. Common Stock (QLGN) free cash flow from Jun 30, 2020 to Sep 30, 2025. The TTM Qualigen Therapeutics, Inc. Common Stock (QLGN) free cash flow is -$7.10M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Qualigen Therapeutics, Inc. Common Stock (QLGN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -26.95% |
| 3 Years TTM | -20.25% |
| 5 Years TTM | +0.72% |
| All Time TTM | -13.94% |
Annual Free Cash Flow change of Qualigen Therapeutics, Inc. Common Stock (QLGN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$4.83M | -23.70% |
| 2024 | -$6.33M | -38.54% |
| 2023 | -$10M | -22.26% |
| 2022 | -$13M | -10.83% |
| 2021 | -$15M | +116.93% |
| 2020 | -$6.85M | N/A |